Clinical trial / 2019
A clinical trial protocol describes evaluating popular antiaging practices and their combinations using DNA methylation age over 2 years in 5,000 participants.
Researchers initiated a clinical trial protocol recruiting 5,000 subjects aged 45-65 to evaluate popular antiaging practices, including diet, drugs, supplements, and exercise. Participants provide blood samples to measure methylation age at the beginning, middle, and end of a 2-year period, with the primary endpoint being the difference in methylation age over 2 years. The exploratory study aims to detect whether certain combinations of strategies synergize to achieve age retardation of 25% or more.
- Study type
- Clinical trial protocol
- Who was studied
- 5,000 subjects aged 45-65
- What was measured
- Difference in methylation age over the course of 2 years
THE PAPER
A Clinical Trial Using Methylation Age to Evaluate Current Antiaging Practices.
Mitteldorf J. Rejuvenation Res, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.